SCHEMBL7382852

SCHEMBL7382852

C=C(C(=O)OCC)C(c1ccc(C(=O)OC(C)(C)C)nc1)C(C)C.CCOC(=O)C(CSC(C)=O)C(c1ccc(NC(=O)OC(C)(C)C)nc1)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6058748 0.86 MAPT (0.34) —
SCHEMBL6059079 0.80 TRPA1 (0.35) —
SCHEMBL6059200 0.78 MAPT (0.35) —
SCHEMBL7379740 0.77 MAPKAPK2 (0.32) —
SCHEMBL6058746 0.76 CYP17A1 (0.36) —
SCHEMBL6058794 0.74 GRIN2B (0.37) —
SCHEMBL6058917 0.73 POLB (0.38) —
SCHEMBL6058911 0.72 CYP17A1 (0.38) —
SCHEMBL6059388 0.72 GRIN2B (0.39) —
SCHEMBL6059026 0.70 GRIN2B (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1180098-A1 NEW COMPOUNDS AstraZeneca AB (SE) 2002-02-20 — — EP disclosed
WO-2000066557-A1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2000-11-09 — — WO disclosed
Send feedback